-
1.发明授权METHOD FOR SEPARATING ANALOGOUS ORGANIC COMPOUNDS 有权VERFAHREN ZUR TRENNUNG ANALOGER ORGANISCHER VERBINDUNGEN
公开(公告)号：EP1183261B1
公开(公告)日：2004-09-01
申请号：EP00927830.0
申请日：2000-05-19
发明人： NISHIHARA, Yutaka , HONDA, Keiji , MUKAI, Koji , HASHIMOTO, Norihiro , HATANAKA, Hiroshi , YAMASHITA, Michio
IPC分类号： C07D498/16
CPC分类号： C07D498/18 , B01D15/185 , B01D2215/023 , B01J39/05 , B01J39/20 , B01J39/26
摘要： A method for separating a lactone-containing high-molecular weight compound having an alkyl group as its side chain from a lactone-containing high-molecular weight compound having an alkenyl group as its side chain, the lactone-containing high-molecular weight compounds having a common basic chemical structure, with use of a sulfonic acid group-containing strong cation exchange resin pretreated with silver ions.
摘要翻译： 本发明涉及通过使用磺酸基从具有烯基作为侧链的含内酯的高分子量化合物分离具有烷基作为侧链的含内酯的高分子量化合物的方法 含有银离子预处理的阳离子交换树脂。
-
2.发明公开SUBSTANCE WF16616, PROCESS FOR PRODUCTION THEREOF, AND USE THEREOF 失效SUBSTANZ WF16616，HERSTELLUNGSPROZESS UND VERWENDUNG
公开(公告)号：EP0846699A1
公开(公告)日：1998-06-10
申请号：EP96918875.4
申请日：1996-06-21
摘要： WF16616 substance represented by the following structural formula (1) or its pharmaceutically acceptable salt.
WF16616 substance exhibits an antimicrobial activity, especially an excellent antifungal activity.摘要翻译： WF16616物质由下述结构式（1）表示，或其药学上可接受的盐。
WF16616物质表现出抗菌活性，特别是优异的抗真菌活性。 -
公开(公告)号：EP1183261A1
公开(公告)日：2002-03-06
申请号：EP00927830.0
申请日：2000-05-19
发明人： NISHIHARA, Yutaka , HONDA, Keiji , MUKAI, Koji , HASHIMOTO, Norihiro , HATANAKA, Hiroshi , YAMASHITA, Michio
IPC分类号： C07D498/16
CPC分类号： C07D498/18 , B01D15/185 , B01D2215/023 , B01J39/05 , B01J39/20 , B01J39/26
摘要： A method for separating a lactone-containing high-molecular weight compound having an alkyl group as its side chain from a lactone-containing high-molecular weight compound having an alkenyl group as its side chain, the lactone-containing high-molecular weight compounds having a common basic chemical structure, with use of a sulfonic acid group-containing strong cation exchange resin pretreated with silver ions.
-
公开(公告)号：EP0941237A1
公开(公告)日：1999-09-15
申请号：EP97912495.0
申请日：1997-11-18
发明人： KANASAKI, Ryuichi , TAKASE, Shigehiro , HASHIMOTO, Michizane , HATANAKA, Hiroshi , SAKAMOTO, Kazutoshi , HASHIMOTO, Seiji , SHIRAISHI, Nobuyuki , OHKI, Hidenori , KAWABATA, Kohji
摘要： This invention relates to new polypeptide compounds represented by formula (I), wherein R1 is as defined in the description or a salt thereof, which have antimicrobial activities (especially, antifungal activities), inhibitory activity on β-1,3-glucan synthase, to a process for preparation thereof, to a pharmaceutical composition comprising the same, and to a method for the prophylactic and/or therapeutic treatment of infectious diseases including Pneumocystis carinii infection (e.g. Pneumocystis carinii pneumonia) in a human being or an animal.
-
公开(公告)号：EP0629184A1
公开(公告)日：1994-12-21
申请号：EP93905607.0
申请日：1993-03-03
发明人： GOTO, Toshio , SHIBATA, Toshihiro , OKUHARA, Masakuni , SAKAMOTO, Kazutoshi , HATANAKA, Hiroshi , TAKASE, Shigehiro , SATO, Tomoko
CPC分类号： C07C69/732 , C07C59/54 , C07D309/30 , C12P7/42 , C12P17/06 , C12P17/12
摘要： L'invention porte sur de nouveaux dérivés de tétraline ayant une activité inhibitrice contre la réductase de 3-hydroxy-3-méthylglutaryl-coenzyme A, représentés par la formule générale (I) dans laquelle R1 est hydrogène ou acétyle, R2 est carboxy et R3 est hydroxy, ou R2 et R3 peuvent former un lactone, et sels acceptables sur le plan pharmaceutique. L'invention se rapporte également à des procédés de production de ces composés, ainsi qu'à une composition pharmaceutique en renfermant.
-
公开(公告)号：EP0983297A1
公开(公告)日：2000-03-08
申请号：EP98919630.8
申请日：1998-05-18
发明人： HORI, Yasuhiro , TSURUMI, Yasuhisa , TAKASE, Shigehiro , HATANAKA, Hiroshi , SAKAMOTO, Kazutoshi , HASHIMOTO, Seiji , OHKI, Hidenori , TOJO, Takashi , MATSUDA, Keiji , KAWABATA, Kohji
摘要： The invention relates to new polypeptide compounds represented by formula (I), wherein R1 is hydrogen, etc., R2 is hydrogen, etc., R3 is hydrogen, etc., and R4 is hydrogen, etc., or a salt thereof which have antimicrobial activities (especially antifungal activities), inhibitory activity on β-1,3-glucan synthase, to process for preparation thereof, to a pharmaceutical composition comprising the same, and to a method for the prophylactic and/or therapeutic treatment of infectious diseases including Pneumocystis carinii infection (e.g. Pneumocystis carinii pneumonia in a human being or an animal.
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.012 秒)
